摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(5-fluoro-1H-indazol-3-yl)(phenyl)amine | 1041613-20-0

中文名称
——
中文别名
——
英文名称
(5-fluoro-1H-indazol-3-yl)(phenyl)amine
英文别名
5-fluoro-N-phenyl-1H-indazol-3-amine
(5-fluoro-1H-indazol-3-yl)(phenyl)amine化学式
CAS
1041613-20-0
化学式
C13H10FN3
mdl
——
分子量
227.241
InChiKey
GHDJDHSMXDYDEZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    40.7
  • 氢给体数:
    2
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    C13H9F2NS 在 作用下, 以 二甲基亚砜 为溶剂, 以86%的产率得到(5-fluoro-1H-indazol-3-yl)(phenyl)amine
    参考文献:
    名称:
    An efficient route to 3-aminoindazoles and 3-amino-7-azaindazoles
    摘要:
    A non-acidic procedure for the preparation of 3-aminoindazoles and 3-amino-7-azaindazoles from 2-fluoroaryl carboxylic acids is reported. The synthesis starts from readily available starting materials and uses mild and practical reaction conditions in a three-step overall procedure. Products were isolated for a number of examples, but yields varied significantly depending on electronic nature of the substituents. (c) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2008.05.100
点击查看最新优质反应信息

文献信息

  • Methods and compositions for the treatment of pain, inflammation and cancer
    申请人:Barbosa Joseph
    公开号:US20080194557A1
    公开(公告)日:2008-08-14
    This invention relates to methods of treating, managing and preventing pain, inflammation, cancer, and ocular diseases and disorders, and to compounds and pharmaceutical compositions useful in such methods.
    本发明涉及用于治疗、管理和预防疼痛、炎症、癌症和眼部疾病和障碍的方法,以及在这些方法中有用的化合物和制药组合物。
  • Methods and compositions for the treatment of body composition disorders
    申请人:Barbosa Joseph
    公开号:US20080200458A1
    公开(公告)日:2008-08-21
    This invention relates to methods of treating, managing and preventing body composition disorders, and to compounds and pharmaceutical compositions useful in such methods.
    本发明涉及治疗、管理和预防身体组成失调的方法,以及在这些方法中有用的化合物和制药组合物。
  • [EN] METHODS AND COMPOSITIONS FOR THE TREATMENT OF PAIN, INFLAMMATION AND CANCER<br/>[FR] MÉTHODES ET COMPOSITIONS UTILISÉS DANS LE TRAITEMENT DE LA DOULEUR, DE L'INFLAMMATION ET DU CANCER
    申请人:LEXICON PHARMACEUTICALS INC
    公开号:WO2008089307A2
    公开(公告)日:2008-07-24
    [EN] This invention relates to methods of treating, managing and preventing pain, inflammation, cancer, and ocular diseases and disorders, and to compounds and pharmaceutical compositions useful in such methods.
    [FR] Cette invention porte sur des méthodes de traitement, de gestion et de prévention de la douleur, de l'inflammation, du cancer et de maladies et troubles oculaires, ainsi que sur des composés et des compositions pharmaceutiques utilisées dans ces méthodes.
  • [EN] METHODS AND COMPOSITIONS FOR THE TREATMENT OF BODY COMPOSITION DISORDERS<br/>[FR] MÉTHODES ET COMPOSITIONS UTILISÉES DANS LE TRAITEMENT DE TROUBLES CORPORELS
    申请人:LEXICON PHARMACEUTICALS INC
    公开号:WO2008089310A2
    公开(公告)日:2008-07-24
    [EN] This invention relates to methods of treating, managing and preventing body composition disorders, and to compounds and pharmaceutical compositions useful in such methods.
    [FR] Cette invention porte sur des méthodes de traitement, de gestion et de prévention de troubles corporels, ainsi que sur des composés et des compositions pharmaceutiques utilisés dans ces méthodes.
  • An efficient route to 3-aminoindazoles and 3-amino-7-azaindazoles
    作者:Michael J. Burke、Brian M. Trantow
    DOI:10.1016/j.tetlet.2008.05.100
    日期:2008.7
    A non-acidic procedure for the preparation of 3-aminoindazoles and 3-amino-7-azaindazoles from 2-fluoroaryl carboxylic acids is reported. The synthesis starts from readily available starting materials and uses mild and practical reaction conditions in a three-step overall procedure. Products were isolated for a number of examples, but yields varied significantly depending on electronic nature of the substituents. (c) 2008 Elsevier Ltd. All rights reserved.
查看更多